insulin drugs glp 1 receptor agaonist market Glucagon-Like Peptide (GLP-1) Agonist Size & Share 2032 GLP-1 Agonists Market Size, Share,

Katsanos CS, Kobayashi H, Sheffield-Moore M, Aarsland A, Wolfe RR

Market Concentration and Competitive Landscape To learn more about this report, Current Events and Their Impact on the GLP-1 Receptor Agonist Market Uncover macros and micros vetted on 75+ parameters: Get instant access to report Market Trends Rising Prevalence of Type 2 Diabetes and Obesity Globally The world is witnessing an alarming surge in the prevalence of type 2 diabetes and obesity, which is a major catalyst for the rapid expansion of the GLP1 receptor agonist market

10.1038/s41598-017-19055-6 48

Circulating levels of Gastrointestinal hormones in response to the most common types of bariatric surgery and predictive value for weight loss over one year: evidence from two independent trials

Access and Equity Considerations The high cost of GLP-1 RAs raises major concerns about health equity and access

Published in 2019, it did not show superiority in reducing MACE, but it provided valuable evidence regarding the safety and oral delivery of GLP-1 receptor agonists, expanding treatment options for patients with T2D (43)